CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC was delisted on the 23rd of June, 2023.
86 hedge funds and large institutions have $79.1M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 17 closing their positions.
507% more call options, than puts
Call options by funds: $1.74M | Put options by funds: $286K
9% less funds holding
Funds holding: 95 → 86 (-9)
18% less capital invested
Capital invested by funds: $97M → $79.1M (-$17.9M)
35% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 31
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$17.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.44M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$795K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$566K |
| 5 |
Barclays
London,
United Kingdom
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$2.87M |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$2.53M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.08M |
| 4 |
PCM
Pyrrho Capital Management
New York
|
-$1.19M |
| 5 |
Renaissance Technologies
New York
|
-$1.09M |
CTIC Hedge Fund Activity: Q3 2015 in Review
86 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q3 2015, worth a combined $79.1M — down 18% from $97M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CTIC and 8 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 20 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $17.3M. The largest seller was Jane Street, cutting an estimated $2.87M.
- 86 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q3 2015, down from 95 in Q2 2015.
- Funds reported $79.1M of CTI BioPharma Corp. (DE) Common Stock stock for Q3 2015, down 18% quarter-over-quarter.
- 8 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q3 2015 and 17 closed out, a net change of -9 holders.
- The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q3 2015 was BVF Inc, an estimated $17.3M added.
- The largest CTI BioPharma Corp. (DE) Common Stock seller in Q3 2015 was Jane Street, an estimated $2.87M sold.
Based on aggregated 13F filings for Q3 2015.